Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

NCT01489423 · clinicaltrials.gov ↗
COMPLETED
Status
270
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Eastern Cooperative Oncology Group

Collaborators